Jeffrey Adam Novack sold $82k of CDNA
Secretary and General Counsel at CareDx, Inc.. 3,512 shares at an average of $23.30, traded Feb 4, 2025, filed Feb 5, 2025.
Score components
- +15RoleOfficer
- +9Trade size$82k at market
- 0Share of holdings soldSold 3.2% of holdings
- 0ClusterNo other insider selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0002019976-25-000002, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 3, 2025 | FTax withholding Common Stock10b5-1 | -2,048 | $23.32 | $48k | 108,189 | Feb 5, 2025 |
| Feb 4, 2025 | SOpen-market sale Common Stock10b5-1 | -3,512 | $23.30 | $82k | 104,677 | Feb 5, 2025 |
Related signals
Other insiders at CareDx, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 12Weak | CareDx, Inc. | Jeffrey Adam Novack Secretary and General Counsel | $91k 4,441 shares | -3% | |
| 29Weak | CareDx, Inc. | John Walter Hanna JR President and CEO | $412k 19,480 shares | -3% | |
| 17Weak | CareDx, Inc. | John Walter Hanna JR President and CEO | $214k 10,156 shares | -2% | |
| 6Weak | CareDx, Inc. | Jeffrey Adam Novack Secretary and General Counsel | $140k 7,293 shares | -7% | |
| 1Weak | CareDx, Inc. | Jeffrey Adam Novack Secretary and General Counsel | $42k 2,688 shares | -2% | |
| 1Weak | CareDx, Inc. | Jeffrey Adam Novack Secretary and General Counsel | $34k 2,688 shares | -2% | |
| 7Weak | CareDx, Inc. | Peter Maag director | $186k 10,000 shares | -3% | |
| 27Weak | CareDx, Inc. | Hannah Valantine director | $203k 10,570 shares | -21% | |
| 22Weak | CareDx, Inc. | Peter Maag director | $192k 10,000 shares | -3% | |
| 41Moderate | CareDx, Inc. | William A Hagstrom director | $386k 19,391 shares | -26% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.